WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt

Recruiting N/A Interventional Study
Suicide, Attempted Suicidal Ideation Depression
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 90
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
115 (estimated)
Sponsor
Weill Medical College of Cornell University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of this project is to test whether WellPATH-PREVENT (a novel, mobile psychosocial intervention) improves a specific aspect of emotion regulation, i.e., cognitive reappraisal ability, and reduces suicide risk in middle-aged and older adults (50-90 years old) who have been discharged after a suicide-related hospitalization (i.e. for suicidal ideation or suicide attempt).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 50-90 years old * Diagnosis (based on a modified SCID-5 Clinical Trials Version to assess DSM-5 diagnoses): Any DSM-5 except: current diagnosis of Psychotic Disorder; diagnosis of Dementia * Recent hospitalization for suicidal ideation or suicide attempt; at hospital admission…
Contacts

Dimitris Kiosses, PhD

914-997-4381

dkiosses@med.cornell.edu

CONTACT

Laurie Evans, MS

914-682-9100

lad9011@med.cornell.edu

CONTACT